Soros Fund Management 13F holdings, Q3 2000
Holdings as of September 30, 2000 · filings on SEC EDGAR · latest filing →
Soros Fund Management disclosed 310 US equity positions worth $2.1bn in its Q3 2000 13F filing. The largest position was PRAECIS PHARMACEUTICALS INC at 5.4% of the reported book, followed by PAINE WEBBER GROUP INC and JENRETTE NW. Against the Q2 2000 filing, it opened 13 new positions, added to 18 and reduced 5 among the top 50 holdings.
What did Soros Fund Management own in Q3 2000? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2000 |
|---|---|---|---|---|---|---|---|
| 1 | PRAECIS PHARMACEUTICALS INC | 5.4% | $114.6m | 2,695,414 | 0% | held | |
| 2 | PAINE WEBBER GROUP INC | 4.8% | $103.7m | 1,522,000 | – | new | |
| 3 | JENRETTE NW | 4.1% | $87.6m | 979,600 | – | new | |
| 4 | ALTEON WEBSYSTEMS INC | 4.1% | $87.4m | 806,600 | – | new | |
| 5 | MMC NETWORKS INC | 4.0% | $85.1m | 672,500 | – | new | |
| 6 | RATIONAL SOFTWARE CORP SUB NT CV 144A07 | 2.6% | $55.7m | 26,900,000 | -24% | reduced | |
| 7 | JUNIPER NETWORKS INC SB NT CV 4.75%07 | 2.5% | $54.1m | 35,750,000 | 27% | added | |
| 8 | YOUNG & RUBICAM INC | 2.1% | $45.7m | 924,200 | 671% | added | |
| 9 | CURAGEN CORP | 1.8% | $37.6m | 705,000 | -63% | reduced | |
| 10 | APEX SILVER MINES LTD | 1.6% | $34.5m | 3,405,071 | 0% | held | |
| 11 | SEAGRAM LTD | 1.5% | $32.9m | 572,700 | 3595% | added | |
| 12 | CHIRON CORP SB CV ADJ 144A00 | 1.3% | $28.9m | 18,657,000 | -16% | reduced | |
| 13 | CROSSWORLDS SOFTWARE INC | 1.2% | $26.1m | 1,321,586 | 0% | held | |
| 14 | MERCURY INTERACTIVE CORP SB NT CV 144A 07 | 1.2% | $25.7m | 16,500,000 | – | new | |
| 15 | WIND RIVER SYSTEMS INC SUB NT CONV 5%02 | 1.1% | $24.5m | 16,540,000 | 94% | added | |
| 16 | PE CORP | 1.1% | $24.3m | 208,588 | 0% | held | |
| 17 | MU MICRON TECHNOLOGY INC | Technology | 1.1% | $24.1m | 523,150 | 483% | added |
| 18 | DEXTER CORP | 1.1% | $23.6m | 318,700 | – | new | |
| 19 | INTC INTEL CORP | Technology | 1.1% | $23.1m | 556,000 | 1327% | added |
| 20 | CONEXANT SYSTEMS INC SB NT CV 4.25%06 | 1.0% | $21.9m | 11,500,000 | 130% | added | |
| 21 | AMERICAN TOWER CORP NT CV 2.25%09 | 1.0% | $21.0m | 17,500,000 | 133% | added | |
| 22 | CYPRESS SEMICONDUCTOR CORP SUB NT CV 4%05 | 1.0% | $21.0m | 18,500,000 | 1133% | added | |
| 23 | LSI LOGIC CORP SUB NT CV 4%05 | 1.0% | $21.0m | 26,000,000 | 30% | added | |
| 24 | VRTX VERTEX PHARMACEUTICALS INC | Healthcare | 0.9% | $19.4m | 229,738 | 100% | added |
| 25 | I2 TECHNOLOGIES INC SUBNTCV 144A 06 | 0.9% | $19.4m | 7,500,000 | 0% | held | |
| 26 | AXA FINL INC | 0.9% | $18.9m | 370,100 | – | new | |
| 27 | COMPAQ COMPUTER CORP | 0.8% | $17.8m | 645,400 | 257% | added | |
| 28 | VOICESTREAM WIRELESS CORP | 0.8% | $17.5m | 151,090 | – | new | |
| 29 | ROGERS COMMUNICATIONS INC DB CONV 2.00%05 | 0.8% | $17.0m | 24,000,000 | 9% | added | |
| 30 | ALZA CORP DEL SUB LYON ZERO 14 | 0.8% | $16.4m | 17,800,000 | -36% | reduced | |
| 31 | LLY LILLY ELI & CO | Healthcare | 0.8% | $16.1m | 198,750 | 15% | added |
| 32 | LATTICE SEMICONDUCTOR CORP SUB NT CV4.75%06 | 0.7% | $15.9m | 10,950,000 | 41% | added | |
| 33 | AMGN AMGEN INC | Healthcare | 0.7% | $15.2m | 218,000 | 0% | held |
| 34 | NIKU CORP | 0.7% | $14.6m | 600,000 | 0% | held | |
| 35 | WEATHERFORD INTL INC SD CV ZRO 144A20 | 0.7% | $14.3m | 25,000,000 | – | new | |
| 36 | ABGENIX INC | 0.6% | $13.7m | 169,000 | 100% | added | |
| 37 | PEOPLESOFT INC | 0.6% | $13.3m | 476,050 | 18% | added | |
| 38 | WORLDCOM INC GA NEW | 0.6% | $12.9m | 425,050 | – | new | |
| 39 | INC | 0.6% | $12.6m | 85,941 | 0% | held | |
| 40 | MCK MCKESSON HBOC INC | Healthcare | 0.6% | $12.2m | 398,050 | – | new |
| 41 | ALKERMES INC | 0.5% | $11.4m | 294,830 | 0% | held | |
| 42 | SEPRACOR INC SB DB CV 144A 07 | 0.5% | $11.2m | 7,500,000 | 0% | held | |
| 43 | LSI LOGIC CORP SB NT CV 4.25%04 | 0.5% | $10.8m | 5,500,000 | – | new | |
| 44 | IDEC PHARMACEUTICALS CORP | 0.5% | $10.3m | 58,940 | 0% | held | |
| 45 | HUMAN GENOME SCIENCES INC | 0.5% | $10.1m | 58,420 | 0% | held | |
| 46 | BSX BOSTON SCIENTIFIC CORP | Healthcare | 0.5% | $9.9m | 600,000 | 50% | added |
| 47 | ANIXTER INTL INC LYON ZERO 144A20 | 0.5% | $9.8m | 35,000,000 | – | new | |
| 48 | TRIMERIS INC | 0.4% | $9.2m | 131,900 | 0% | held | |
| 49 | ELANTEC SEMICONDUCTOR INC | 0.4% | $9.2m | 92,400 | -19% | reduced | |
| 50 | ORTEC INTL INC | 0.4% | $9.2m | 782,500 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.